Michael Tanaka, MD

Clinical Professor

  • 1654 Citations
  • 12 h-Index
1980 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1654 Citations
  • 12 h-Index
  • 20 Article
2017

Phase II study of dovitinib in patients progressing on anti-vascular endothelial growth factor therapy

Semrad, T., Kim, E., Tanaka, M., Sands, J., Roberts, C., Burich, R. A., Li, Y., Gandara, D. R., Lara, P. N. & Mack, P., Jan 1 2017, In : Cancer Treatment and Research Communications. 10, p. 21-26 6 p.

Research output: Contribution to journalArticle

6 Scopus citations
2014

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results

Semrad, T., Barzi, A., Lenz, H. J., Hutchins, I. M., Kim, E., Gong, I. Y., Tanaka, M., Beckett, L. A., Holland, W., Burich, R. A., Snyder-Solis, L., Mack, P. & Lara, P. N., Aug 5 2014, In : International Journal of Clinical Oncology. 20, 3, p. 518-524 7 p.

Research output: Contribution to journalArticle

12 Scopus citations
2011

Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study

Ho, C., Sangha, R., Beckett, L. A., Tanaka, M., Lau, D. H., Eisen, D. B., Burich, R. A., Luciw, P. A., Khan, I., Mack, P., Gandara, D. R. & Davies, A. M., Aug 2011, In : Investigational New Drugs. 29, 4, p. 680-687 8 p.

Research output: Contribution to journalArticle

11 Scopus citations
2009

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., Mack, P., Lurje, G., Gandour-Edwards, R. F., Dancey, J. & Gandara, D. R., Sep 2009, In : Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

Research output: Contribution to journalArticle

182 Scopus citations
2008

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033

Blanke, C. D., Rankin, C., Demetri, G. D., Ryan, C. W., Von Mehren, M., Benjamin, R. S., Raymond, A. K., Bramwell, V. H. C., Baker, L. H., Maki, R. G., Tanaka, M., Randolph Hecht, J., Heinrich, M. C., Fletcher, C. D. M., Crowley, J. J. & Borden, E. C., Feb 1 2008, In : Journal of Clinical Oncology. 26, 4, p. 626-632 7 p.

Research output: Contribution to journalArticle

732 Scopus citations

Population-based phase i trial of irinotecan and epirubicin

Lau, D. H., Johl, J., Huynh, M., Davies, A., Tanaka, M., Lara, P. N. & Gandara, D. R., Jun 2008, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 31, 3, p. 226-230 5 p.

Research output: Contribution to journalArticle

2 Scopus citations
2007

A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer

Wang, H., Ryu, J., Gandara, D. R., Bold, R. J., Urayama, S., Tanaka, M., Goldberg, Z., Follette, D., Narayan, S. & Lau, D. H., Feb 2007, In : Journal of Thoracic Oncology. 2, 2, p. 153-157 5 p.

Research output: Contribution to journalArticle

31 Scopus citations
19 Scopus citations
2006

Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144

Smalley, S. R., Benedetti, J. K., Williamson, S. K., Robertson, J. M., Estes, N. C., Maher, T., Fisher, B., Rich, T. A., Martenson, J. A., Kugler, J. W., Benson, A. B., Haller, D. G., Mayer, R. J., Atkins, J. N., Cripps, C., Pedersen, J., Periman, P. O., Tanaka, M. S., Leichman, C. G. & Macdonald, J. S., Aug 1 2006, In : Journal of Clinical Oncology. 24, 22, p. 3542-3547 6 p.

Research output: Contribution to journalArticle

132 Scopus citations

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

Whitehead, R. P., McCoy, S., Macdonald, J. S., Rivkin, S. E., Neubauer, M. A., Dakhil, S. R., Lenz, H. J., Tanaka, M. & Abbruzzese, J. L., Jul 2006, In : Investigational New Drugs. 24, 4, p. 335-341 7 p.

Research output: Contribution to journalArticle

10 Scopus citations
2004
26 Scopus citations
2003

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors

Lim, N., Lara, P. N., Lau, D. H., Edelman, M. J., Tanaka, M., Al-Jazayrly, G., Houston, J., Lauder, I. & Gandara, D. R., 2003, In : Cancer Investigation. 21, 1, p. 7-13 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Population-based maximum tolerated dose of irinotecan and carboplatin.

Wild, C. A., Wang, S. E., Gandara, D. R., Lara, P. N., Meyers, F. J., Tanaka, M., Houston, J., Lauder, J. & Lau, D. H., Jul 2003, In : Oncology (Williston Park, N.Y.). 17, 7 Suppl 7, p. 11-16 6 p.

Research output: Contribution to journalArticle

4 Scopus citations
2002

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: A Southwest Oncology Group study

Rothenberg, M. L., Benedetti, J. K., Macdonald, J. S., Seay, T. E., Neubauer, M. A., George, C. S., Tanaka, M., Giguere, J. K., Pruitt, B. T. & Abbruzzese, J. L., Oct 1 2002, In : Annals of Oncology. 13, 10, p. 1576-1582 7 p.

Research output: Contribution to journalArticle

20 Scopus citations

Premedication strategy for weekly paclitaxel

Quock, J., Dea, G., Tanaka, M., Gandara, D. R., Lara, P. N. & Lau, D. H., 2002, In : Cancer Investigation. 20, 5-6, p. 666-672 7 p.

Research output: Contribution to journalArticle

32 Scopus citations
2001
390 Scopus citations
1991
17 Scopus citations
1988

Conjugated estrogen for platelet dysfunction associated with liver disease

Perez, E. A., Tanaka, M. & Gandara, D. R., 1988, In : New England Journal of Medicine. 318, 23, p. 1543 1 p.

Research output: Contribution to journalArticle

1983

Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices

Shaw, S. T., Macaulay, L. K., Sun, N. C., Tanaka, M. & Roche, P. C., 1983, In : Contraception. 27, 2, p. 131-140 10 p.

Research output: Contribution to journalArticle

9 Scopus citations
1980

Plasminogen activator in human uterine tissue. Relationship to location of sampling and time in ovarian cycle

Shaw, S. T., Macaulay, L. K., Tanaka, M., Hohman, W. R., Moyer, D. L. & Sun, N. C., 1980, In : Biochemical Medicine. 24, 2, p. 170-178 9 p.

Research output: Contribution to journalArticle

12 Scopus citations